Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group.

Takenaka, T

Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group. [electronic resource] - Japanese journal of clinical oncology Oct 1999 - 485-9 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0368-2811

10.1093/jjco/29.10.485 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--administration & dosage
Drug Administration Schedule
Drug Evaluation
Female
Humans
Male
Melphalan--administration & dosage
Middle Aged
Multiple Myeloma--drug therapy
Prednisone--administration & dosage
Survival Rate
Vincristine--administration & dosage